MUMBAI, India, June 16 -- Intellectual Property India has published a patent application (202611053954 A) filed by Dr. Kriti Shrinet; Dr. Riden Saxena; Dr. Ritika Saxena; and Dr. Satish Chandra, Moradabad, Uttar Pradesh, on April 28, for 'gastric fluid-resistant proteinaceous nanocomposite loaded with antimicrobial peptides for selective gastrointestinal pathogen clearance.'
Inventor(s) include Dr. Kriti Shrinet; Dr. Riden Saxena; Dr. Ritika Saxena; and Dr. Satish Chandra.
The application for the patent was published on June 5, under issue no. 23/2026.
According to the abstract released by the Intellectual Property India: "The present invention describes a gastric fluid-resistant proteinaceous nanocomposite designed for targeted delivery of antimicrobial peptides to the gastrointestinal tract. The system protects peptides from acidic degradation and enzymatic activity in the stomach through a cross-linked protein matrix and protective coatings. Upon reaching the intestine, the nanocomposite enables controlled release triggered by environmental pH changes. The released antimicrobial peptides selectively target pathogenic bacteria while preserving beneficial microbiota. This approach enhances bioavailability, reduces antimicrobial resistance, and improves therapeutic outcomes. The invention offers a biocompatible, biodegradable, and efficient alternative to conventional antibiotic therapies for the treatment of gastrointestinal infections and related disorders."
Disclaimer: Curated by HT Syndication.
